Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib

NCT03386825 · clinicaltrials.gov ↗

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Regorafenib (Stivarga, BAY73-4506)

Sponsor

Bayer